top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
A House Veterans' Affairs subcommittee will hold a hearing this week on expanding veterans' access to psychedelic treatments, with VA officials set to testify.

House Panel Takes Up Psychedelic Therapy for Veterans This Week

Nov 17, 2026

Source:

Tom Angell

Marijuana Moment

Congress is turning its attention to psychedelic treatment for military veterans this week. A House committee has scheduled a hearing on increasing veterans' access to these therapies, and officials from the US Department of Veterans Affairs are slated to testify. They will appear alongside medical professionals and researchers, giving lawmakers a mix of government, clinical, and scientific perspectives.

The hearing is titled Psychedelic-Assisted Therapies for Veterans: The Path Forward and will take place before the House Veterans' Affairs Subcommittee on Health. The name signals the focus. Rather than debating whether these treatments deserve a look, the session is framed around what comes next and how access could be expanded.

Interest in psychedelic-assisted therapy among veterans has grown in recent years, driven by hopes that it could help with conditions such as post-traumatic stress and depression that affect many who have served. Advocates have pushed for more research and more pathways to care, while the VA has been under pressure to explain how it plans to approach the field. Having agency officials testify in public gives lawmakers a chance to ask direct questions about current research, policy, and timelines.

The researchers and clinicians on the panel can add detail about what the evidence shows and what barriers remain. Those could include regulatory hurdles, funding, and the practical challenge of delivering this kind of therapy safely within a large health system.

A hearing alone does not change policy, but it can set the tone for future legislation and funding decisions. For veterans and advocates who have been waiting for movement, this week's session is a visible sign that psychedelic therapy remains on the congressional agenda. What lawmakers and VA officials say could offer early clues about how quickly any expansion might happen.

Recent Reviews

bottom of page